Clinician education needed to improve HPV4 vaccine rate for young male adolescents in primary care
Increased clinician education is necessary to improve HPV4 vaccination rates in primary care settings.
Increased clinician education and the development of evidence-based tools are needed to improve quadrivalent human papillomavirus vaccine (HPV4) implementation rates in a primary care setting, according to a survey conducted by the Advisory Committee on Immunization Practices (ACIP).
Between July and September of 2010, the ACIP conducted a mail and internet survey targeting a nationally representative sample of pediatricians and family medicine practitioners. About 72% of all clinicians responded (609 of 842); most believed that they were justified in the routine use of HPV4 vaccination in males; 33% recommended HPV4 to 11- and 12-year-old males, making stronger recommendations to older adolescents.
Clinicians “who reported recommending HPV4 … were more likely to be from urban locations, perceive that HPV4 is efficacious, perceive that HPV-related disease is severe, and routinely discuss sexual health with 11- to 12-year-olds,” wrote study author Mandy A. Allison, MD, MSPH, of the Children's Outcomes Research Program at Children's Hospital Colorado, in Aurora, Colorado.
- Allison MA, Dunne EF, Markowitz LE, et al. HPV vaccination of boys in primary care practices. Acad Pediatr. 2013 Sept-Oct;13(5):446-474. Doi: 10.1016/j.acap.2013.03.006